rs377735574

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_004104.5(FASN):​c.6788G>A​(p.Arg2263Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000556 in 1,601,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2263W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000053 ( 0 hom. )

Consequence

FASN
NM_004104.5 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.669

Publications

0 publications found
Variant links:
Genes affected
FASN (HGNC:3594): (fatty acid synthase) The enzyme encoded by this gene is a multifunctional protein. Its main function is to catalyze the synthesis of palmitate from acetyl-CoA and malonyl-CoA, in the presence of NADPH, into long-chain saturated fatty acids. In some cancer cell lines, this protein has been found to be fused with estrogen receptor-alpha (ER-alpha), in which the N-terminus of FAS is fused in-frame with the C-terminus of ER-alpha. [provided by RefSeq, Jul 2008]
FASN Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12364861).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FASNNM_004104.5 linkc.6788G>A p.Arg2263Gln missense_variant Exon 39 of 43 ENST00000306749.4 NP_004095.4 P49327
FASNXM_011523538.3 linkc.6788G>A p.Arg2263Gln missense_variant Exon 39 of 43 XP_011521840.1 P49327

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FASNENST00000306749.4 linkc.6788G>A p.Arg2263Gln missense_variant Exon 39 of 43 1 NM_004104.5 ENSP00000304592.2 P49327
FASNENST00000634990.1 linkc.6782G>A p.Arg2261Gln missense_variant Exon 39 of 43 5 ENSP00000488964.1 A0A0U1RQF0
FASNENST00000580382.1 linkn.11G>A non_coding_transcript_exon_variant Exon 1 of 5 3 ENSP00000462949.1 J3KTF0
FASNENST00000578424.2 linkn.-35G>A upstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.0000789
AC:
12
AN:
152114
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000350
AC:
8
AN:
228614
AF XY:
0.0000565
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000778
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000531
AC:
77
AN:
1449634
Hom.:
0
Cov.:
33
AF XY:
0.0000458
AC XY:
33
AN XY:
720060
show subpopulations
African (AFR)
AF:
0.0000300
AC:
1
AN:
33380
American (AMR)
AF:
0.0000235
AC:
1
AN:
42588
Ashkenazi Jewish (ASJ)
AF:
0.0000387
AC:
1
AN:
25840
East Asian (EAS)
AF:
0.0000255
AC:
1
AN:
39250
South Asian (SAS)
AF:
0.0000238
AC:
2
AN:
84188
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51306
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5644
European-Non Finnish (NFE)
AF:
0.0000614
AC:
68
AN:
1107496
Other (OTH)
AF:
0.0000500
AC:
3
AN:
59942
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000789
AC:
12
AN:
152114
Hom.:
0
Cov.:
33
AF XY:
0.000108
AC XY:
8
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41422
American (AMR)
AF:
0.0000655
AC:
1
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68014
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000217
Hom.:
0
Bravo
AF:
0.0000491
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.0000333
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 16, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.6788G>A (p.R2263Q) alteration is located in exon 39 (coding exon 38) of the FASN gene. This alteration results from a G to A substitution at nucleotide position 6788, causing the arginine (R) at amino acid position 2263 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Epileptic encephalopathy Uncertain:1
Jul 07, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 572661). This variant has not been reported in the literature in individuals affected with FASN-related conditions. This variant is present in population databases (rs377735574, gnomAD 0.009%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 2263 of the FASN protein (p.Arg2263Gln). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.26
T;.
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.78
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.90
D;D
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.12
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.3
L;.
PhyloP100
0.67
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.86
N;.
REVEL
Benign
0.032
Sift
Benign
0.082
T;.
Sift4G
Benign
0.12
T;T
Polyphen
0.27
B;.
Vest4
0.20
MVP
0.31
ClinPred
0.098
T
GERP RS
-0.91
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.14
gMVP
0.29
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs377735574; hg19: chr17-80038606; API